What Is a ‘Tolerable’ Dose? AACR-Industry Roundtable 2025 Examines Dose Optimization
Experts discussed challenges and opportunities for dose optimization of cancer treatments at the 2025 AACR-Industry Roundtable.
Experts discussed challenges and opportunities for dose optimization of cancer treatments at the 2025 AACR-Industry Roundtable.
Cancer Today's Winter 2024-25 issue covers the benefits of stereotactic body radiation therapy, geriatric assessment in cancer care, and...
Our annual Experts Forecast offers insights from AACR President-Elect Lillian Siu, John E. Dick, Regina Barzilay, Vinod Balachandran, and...
Experts reflected on how clinical decision-making for treating breast cancer may change in light of the latest results shared...
The AACR Cancer Progress Report 2024 detailed the connection between alcohol consumption and the increased risk of certain cancers....
At the San Antonio Breast Cancer Symposium, experts discussed the implications of sexual health, supplements, exercise, and diet for...
In the final three months of 2024, the FDA issued 15 approvals in oncology, including several therapies that are...
This month, the editors of the AACR journals highlighted studies about the gut microbiome in lung cancer, modeling the...
In 2024, the American Association for Cancer Research (AACR) released the 14th edition of the annual AACR Cancer Progress...
A session on molecular degraders at SABCS 2024 highlighted an exciting new frontier for SERDs, PROTACs, LYTACs, and biparatopic...
By Vivek Subbiah, MD, Sarah Cannon Research Institute It is both the best of times and a challenging time...